Two‐Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti‐inflammatory Drug‐Exacerbated Respiratory Disease.
Saved in:
| Title: | Two‐Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti‐inflammatory Drug‐Exacerbated Respiratory Disease. |
|---|---|
| Authors: | Elzinga, H. B. E.1 (AUTHOR) h.b.e.elzinga@amsterdamumc.nl, Otten, J. J.1 (AUTHOR), Cornet, M. E.2 (AUTHOR), Rinia, A. B.3 (AUTHOR), Van Der Lans, R. J. L.1 (AUTHOR), Fokkens, W. J.1 (AUTHOR), Reitsma, S.1 (AUTHOR), Timmer, F. C. A. (AUTHOR), Kleiss, I. J. (AUTHOR), Krebbers, I. (AUTHOR), Adriaensen, G. F. J. P. M. (AUTHOR), Benoist, L. B. L. (AUTHOR), Hoven, D. R. (AUTHOR) |
| Source: | Allergy. Jun2025, Vol. 80 Issue 6, p1737-1745. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
